Sanjay Mistry
InvestorInvestor at Johnson & Johnson Innovation – JJDC
San Diego, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Sanjay
370 people in our graph share verified history with Sanjay — schools, employers, funds. One of them is your warm intro.
Teresa ChanunlockedSanjay: together at Johnson & Johnson (2003–2004)
×6Sanjay: together at Johnson & Johnson
Sanjay: together at Rapport Therapeutics
×2Sanjay: together at University of Aberdeen
About
Sanjay Mistry is Vice President of Venture Investments and New Company Creation at Johnson & Johnson Innovation – JJDC Inc., where he leads the identification and funding of early-stage healthcare companies. He serves as Director on the Board of Agni Bio and has held board positions at TRex Bio and Abdera Therapeutics, as well as prior board roles at companies including Manifest Technologies, Rapport Therapeutics, RainDance Technologies, and Rapid Micro Biosystems. His background includes involvement in the formation of multiple biotech companies, including Provention Bio, Fusion Pharmaceuticals, and Aro Therapeutics, and he holds training in clinical pharmacology with 20 peer-reviewed publications and over 200 issued patents.
Experience
- Agni BioDirector Board of Directorscurrent2024 — presentSD & SSF
- TRexBioDirector Board of Directorscurrent2024 — present
- Johnson & JohnsonVice President Venture Investments - Johnson & Johnson Innovation – JJDC Inc.current2021 — presentSan Diego, California, United States
- Johnson & JohnsonHead JLABS @ San Diego, Johnson & Johnson Innovation2019 — 2021Greater San Diego Area
- Johnson & JohnsonSenior Finance Director Business Operations for Janssen Pharmaceuticals R&D2018 — 2019Springhouse, PA
- Johnson & JohnsonHead of External Value Creation & Business Operations/Venture Leader2013 — 2018Janssen Pharmaceuticals, Springhouse PA
- Abdera TherapeuticsBoard Observer2024 — 2026
- Manifest TechnologiesBoard Observer2021 — 2024Connecticut, United States
- Rapport TherapeuticsDirector Board of Directors2022 — 2024
- Quaker PartnersVice President2008 — 2013Philadelphia
- Johnson & JohnsonAssistant Director2003 — 2008Malvern, PA
- Morphogen PharmaceuticalsDevelopment Scientist2002 — 2003Greater San Diego Area
- The Scripps Research InstitutePostdoctoral Fellow2000 — 2001Greater San Diego Area
- UPMCPostdoctoral Fellow1998 — 2000Greater Pittsburgh Area
Skills & more
Strategic Planning14Clinical Development18Clinical Trials14Stem Cells2Tissue Engineering1Biomaterials1Cell Therapy1Venture Capital31Corporate Development8Commercialization13Biotechnology26Lifesciences6
+3 more
Private EquityDrug DevelopmentINDLanguages French · Gujarati
From Sanjay's professional profile.
Colleagues at Johnson & Johnson Innovation – JJDC
Ahryon Cho
Regional Head, JLABS Korea at Johnson & Johnson Innovation – JJDC
Amir Blatt
Founding Partner and CIO at Almeda Ventures
Anurag Mehta
Principal at Johnson & Johnson Innovation – JJDC
Asha Nayak
Investor at Johnson & Johnson Innovation – JJDC
Asish K. Xavier
Vice President, Venture Investments at JJDC
Aurelie Gaudin
Associate Director, Global Campaigns & Audience Engagement at Johnson & Johnson Innovation – JJDC
Chelsea Hewitt
Senior Director, Regional Engagement & Incubation, San Diego, External Scientific Innovation at Johnson & Johnson Innovation – JJDC
Chris Haskell
Head of JLABS @ San Francisco Bay Area at Johnson & Johnson Innovation – JJDC
Frequently asked questions
- Who is Sanjay Mistry?
- Sanjay Mistry is Vice President of Venture Investments and New Company Creation at Johnson & Johnson Innovation – JJDC Inc., where he leads the identification and funding of early-stage healthcare companies. He serves as Director on the Board of Agni Bio and has held board positions at TRex Bio and Abdera Therapeutics, as well as prior board roles at companies including Manifest Technologies, Rapport Therapeutics, RainDance Technologies, and Rapid Micro Biosystems. His background includes involvement in the formation of multiple biotech companies, including Provention Bio, Fusion Pharmaceuticals, and Aro Therapeutics, and he holds training in clinical pharmacology with 20 peer-reviewed publications and over 200 issued patents.
- Where does Sanjay Mistry work?
- Sanjay Mistry is Investor at Johnson & Johnson Innovation – JJDC.
- What check size does Sanjay Mistry write?
- Sanjay Mistry typically writes checks of $100K – $5M.
- Where did Sanjay Mistry go to school?
- Sanjay Mistry studied at University of Aberdeen (Doctor of Philosophy (Ph.D.), Pharmacology); University of Aberdeen (Master of Science Clinical Pharmacology); Nottingham Trent University (Bachelor’s Degree, Bachelors of Biomedical Science/Pharmacology).
Same school
Also attended University of Aberdeen64
Janet WolpertInvestor at Index VenturesChloe ParamattiInvestor at EQT VenturesIsabelle TressonCommunications & Marketing Lead at Partech VenturesWill CadellVenture Advisor at Cultivation CapitalJai TaylorInvestor at Blue Wire CapitalJohn CampbellEIR at Delin Ventures
+ 58 more
Also attended Nottingham Trent University33
Hristo BorisovCo-founder & CEO of PayhawkVasso FantousiLegal Counsel at RTP GlobalNicki MughalChief of Staff & People Operations Officer at White Star CapitalFiona RooneyGeneral Counsel at InHealth VenturesCharlie SmithFund Coordinator at Mercia VenturesHannah WilliamsonSenior Investment Manager at Edge VC
+ 27 more
Shared employers
Also worked at TRexBio8
Susannah BarbeeVice President, Translational Immunology at Deerfield Management CompanyAlexandra CantleyManaging Partner at Polaris PartnersNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsAlex Badamchi-ZadehVice President at SV Health InvestorsEric HuangPartner at Delos Capital
+ 2 more
Also worked at Johnson & Johnson229
Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners
+ 223 more
